| 03/10/22 | 07:00:07 | 3 Oct 2022 | | Total Voting Rights |
| 30/09/22 | 18:15:03 | 30 Sept 2022 | | Transaction in Own Shares |
| 29/09/22 | 18:15:01 | 29 Sept 2022 | | Transaction in Own Shares |
| 28/09/22 | 18:15:05 | 28 Sept 2022 | | Transaction in Own Shares |
| 27/09/22 | 18:15:06 | 27 Sept 2022 | | Transaction in Own Shares |
| 26/09/22 | 18:15:05 | 26 Sept 2022 | | Transaction in Own Shares |
| 23/09/22 | 18:15:05 | 23 Sept 2022 | | Transaction in Own Shares |
| 22/09/22 | 18:15:05 | 22 Sept 2022 | | Transaction in Own Shares |
| 22/09/22 | 16:00:02 | 22 Sept 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 20/09/22 | 18:15:00 | 20 Sept 2022 | | Transaction in Own Shares |
| 16/09/22 | 18:15:04 | 16 Sept 2022 | | Transaction in Own Shares |
| 15/09/22 | 18:15:00 | 15 Sept 2022 | | Transaction in Own Shares |
| 14/09/22 | 07:00:10 | 14 Sept 2022 | | STATEMENT RE SAREPTA THERAPEUTICS, INC. |
| 14/09/22 | 07:00:10 | 14 Sept 2022 | | Half-yearly Report |
| 31/08/22 | 07:00:05 | 31 Aug 2022 | | Notice of Half Year Results |
| 22/08/22 | 16:53:20 | 22 Aug 2022 | | Statement re Epizyme |
| 19/08/22 | 16:00:03 | 19 Aug 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 16/08/22 | 07:00:11 | 16 Aug 2022 | | Dividend Declaration |
| 09/08/22 | 07:00:03 | 9 Aug 2022 | | STATEMENT RE GLOBAL BLOOD THERAPEUTICS |
| 21/07/22 | 16:00:00 | 21 Jul 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 20/07/22 | 11:11:18 | 20 Jul 2022 | | Statement Re Akebia |
| 11/07/22 | 07:00:04 | 11 Jul 2022 | | Transaction in Own Shares |
| 08/07/22 | 07:00:04 | 8 Jul 2022 | | Transaction in Own Shares |
| 06/07/22 | 17:36:10 | 6 Jul 2022 | | Transaction in Own Shares |
| 05/07/22 | 17:40:46 | 5 Jul 2022 | | Transaction in Own Shares |
| 01/07/22 | 07:00:05 | 1 Jul 2022 | | SHARE BUY-BACK PROGRAMME |
| 28/06/22 | 07:00:04 | 28 Jun 2022 | | STATEMENT RE EPIZYME |
| 23/06/22 | 16:00:01 | 23 Jun 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 09/06/22 | 17:39:36 | 9 Jun 2022 | | Result of AGM |
| 23/05/22 | 16:00:03 | 23 May 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 13/05/22 | 12:35:45 | 13 May 2022 | | Notice of AGM |
| 05/05/22 | 10:25:15 | 5 May 2022 | | Director/PDMR Shareholding |
| 27/04/22 | 17:15:51 | 27 Apr 2022 | | Dividend Declaration |
| 26/04/22 | 11:36:20 | 26 Apr 2022 | | Holding(s) in Company |
| 25/04/22 | 16:00:06 | 25 Apr 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 21/04/22 | 15:18:45 | 21 Apr 2022 | | Results of Placing in BioPharma Credit Plc |
| 20/04/22 | 07:00:04 | 20 Apr 2022 | | Proposed Secondary Placing in BioPharma Credit Plc |
| 22/03/22 | 07:00:06 | 22 Mar 2022 | | Annual Financial Report |
| 21/03/22 | 16:00:02 | 21 Mar 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 10/03/22 | 14:17:04 | 10 Mar 2022 | | NOTICE OF FULL YEAR RESULTS |
| 08/03/22 | 16:30:05 | 8 Mar 2022 | | NEW INVESTMENT |
| 24/02/22 | 15:58:13 | 24 Feb 2022 | | Dividend Declaration |
| 21/02/22 | 16:00:06 | 21 Feb 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 18/02/22 | 16:37:04 | 18 Feb 2022 | | Director/PDMR Shareholding |
| 14/02/22 | 12:30:02 | 14 Feb 2022 | | US$325 MILLION INVESTMENT IN COLLEGIUM |
| 24/01/22 | 16:00:02 | 24 Jan 2022 | | Net Asset Value(s) and Monthly Factsheet |
| 10/01/22 | 07:00:08 | 10 Jan 2022 | | NEW INVESTMENT OF UP TO US$150.0 MILLION |
| 21/12/21 | 16:00:05 | 21 Dec 2021 | | Net Asset Value(s) and Monthly Factsheet |
| 15/12/21 | 07:00:04 | 15 Dec 2021 | | NEW INVESTMENTS OF UP TO US$112.5 MILLION |
| 19/11/21 | 16:00:01 | 19 Nov 2021 | | Net Asset Value(s) and Monthly Factsheet |
